-
UK PM calls for 'honest discussion' about EU free movement
-
Catlin to make Masters debut after cruising to Hong Kong win
-
Far-right leader Le Pen kicks off tilt at French presidency amid nationwide protests
-
Katsuragawa hails 'greatest moment' with South Korea win
-
Naomi Osaka could quit tennis if daughter asks her to
-
Japan's Yoshida wins first LPGA Tour title with South Korea win
-
Last MotoGP race at Phillip Island cancelled due to weather in Marquez setback
-
Comeback kings Brewers down Rays to take 2-0 World Series lead
-
Sri Lanka seeks faster green energy shift after oil shocks
-
Sri Lankan turbine project fuels anger as fish hauls plunge
-
Riyadh airport resumes flights following Houthi attacks
-
No LeBron, no problem as Sixers roll on
-
'Call of Duty' North Korea invasion edition tops sales charts in South
-
Israel to close all land crossings with West Bank on election day
-
Musk accuses Ukraine of violating Starlink's terms of service
-
'Tech debt coming due': AI-found flaw signals chaos ahead
-
Fed expected to hold rates steady days ahead of US midterms
-
Stop-motion 'Wildwood' showcases 'human creativity' in AI age
-
More Lula, or back to the Bolsonaros? Brazil votes in cliffhanger
-
Obama blasts Trump's 'chaos and cruelty' while campaigning for Democrats
-
Jorge Martin out of Australian MotoGP with fracture: team
-
Bolsonaro leads Lula in final Brazil election polls
-
Antonelli storms to US Grand Prix pole on weekend he can take title
-
Antonelli storms to pole for US Grand Prix
-
Apologetic Alvarez fires Atletico to win against Deportivo
-
Alvarez fires Atletico to win against Deportivo
-
Lens beat PFC in Ligue 1 matchday impacted by social unrest
-
Japan's Nakai wins Grand Prix de France for second straight year
-
Valkyries hit back against Dream to level WNBA Finals
-
Ronaldinho to make comeback in Italian third tier
-
'Fighting for our rights': Paris protesters determined to march on
-
Israeli forces displace Hebron families after deadly attack
-
Clashes break out in Paris, other French cities amid fresh protests
-
Hamilton on top with Antonelli fourth in final practice at US Grand Prix
-
Spurs seal rare win at Chelsea as Palmer sees red
-
Beier late show sends Dortmund top of Bundesliga
-
Nearly 1,000 arrested in French protests marred by 'elevated' violence: minister
-
Police and protesters clash again at Albanian anti-government rally
-
France extends detention of suspected racist shooter
-
Arteta hails mentality as Arsenal go level with Man City
-
Andrade and Nemour star as Biles cheers at world gymnastics champs
-
Clashes break out in Paris, other cities amid fresh protests
-
Nigeria's Tinubu defends record as economy bites ahead of election
-
Bouthier kicks Vannes to first Top 14 win of season
-
'Guiding star' Fuellkrug bags Bremen brace, Leipzig win
-
Thousands rally for Lula and Bolsonaro on eve of tight Brazil vote
-
Man City's perfect start ended by Aston Villa, Arsenal go joint-top
-
Red-hot Fuellkrug bags Bremen brace, Leipzig win
-
Arsenal sink Everton to join Man City at Premier League summit
-
Thousands gather at new Albanian anti-government rally
'Constant danger': Life after leprosy, a long neglected disease
Dan Izzett has lived with leprosy's effects on his body for 70 years, and has lost much to what he calls an "ancient, fascinating, very unkind disease".
The Zimbabwean former civil engineering technician and pastor was diagnosed at the age of 25 in 1972, but first contracted the disease when he was just five.
That long incubation period gave the bacteria that causes leprosy, Mycobacterium leprae, lots of time to spread through his body.
His right leg was amputated in 1980 in Zimbabwe's capital Harare. Now 75, Izzett has no feeling above his elbows, below his knees or in 70 percent of his face.
That lack of feeling poses a "constant danger," Izzett told AFP in a phone call from his home in southwest England.
In October 2020, "I put my hands on a hot plate and hadn't noticed it until I could smell my flesh burning," he said, leading to the amputation of the middle finger of his right hand.
The following year, the little toe on his left foot was amputated. Last month, he lost another toe.
Izzett said he chose to speak out about his experience because millions of survivors who were less well off were unable to, partly because of the stigma and discrimination that still surrounds the disease.
- The 'forgotten' patients -
Leprosy, also known as Hansen's disease, has been haunting humanity for at least 4,000 years, often affecting the poorest communities.
It is a considered a neglected tropical disease by the World Health Organization, and remains under researched and little discussed compared to many other illnesses.
In 2021, more than 140,500 new cases were detected worldwide, nearly three quarters of them in Brazil, India and Indonesia, according to the WHO.
However pandemic-related disruptions have led to nearly 40 percent fewer cases being detected a year, with fears that tens of thousands have gone undiagnosed.
Even before the pandemic, the official numbers likely did not reflect reality.
"We know the number of patients who have been tested, but we do not count the forgotten, undetected patients," said Bertrand Cauchoix, a leprosy specialist at the Raoul Follereau Foundation in France.
This is in part because the disease's incubation period can last up to 20 years. Testing and diagnosis also takes time, during which patients could potentially infect their family members.
Before he received his diagnosis, said Izzett, "my wife got the disease from me".
Back in the 1970s, Izzett was given the antibiotic Dapsone, which was then a lifetime treatment.
In the mid-80s, a combination of drugs including Dapsone known as multidrug therapy (MDT) became available. It can cure leprosy over a 12-month course -- though nerve damage and other remnants of the disease remain.
Mathias Duck, a former chaplain in Paraguay's capital Asuncion, only needed six-months of MDT after being diagnosed with leprosy in 2010.
"I consider myself the luckiest person affected by leprosy because I was diagnosed and treated in time and so I have no impairments whatsoever," the 44-year-old told AFP.
The WHO provides MDT to patients worldwide for free, with Swiss pharmaceutical giant Novartis donating doses since 2000.
However there has been little progress for new treatments.
"There is no money for leprosy, only charitable donations," Cauchoix said.
- Don't use the 'L word' -
Alexandra Aubry, a specialist at the Centre for Immunology and Infectious Diseases in France, evaluates whether every new antibiotic developed for other illnesses could also be used for leprosy.
Her laboratory is one of the few in the world able to carry out tests on the leprosy bacteria, which does not survive in a petri dish.
They are trying to find a way to "simplify" treatment so it can take less than six months, she said.
There are also a couple of vaccines being developed, though they remain in early phases of human testing.
"It is very complex to get funding for this," Aubry said.
"To assess the effectiveness of a vaccine, you have to follow the vaccinated population for 10 to 15 years," with the timeframe extended further by the disease's long incubation period, she said.
In comparison to how swiftly the world responded to Covid, leprosy efforts are "a drop in the bucket," Duck said, calling for far more research and political action.
But he added that there is something everyone can do for World Leprosy Day on Sunday -- stop using the word "leper".
"We call it the 'L word'," Duck said, describing it as discriminatory.
"It's a little step that most people can do," he added, "to give people affected by leprosy "the dignity they deserve".
Y.Shaath--SF-PST